Princeton Biopharma Capital Partners
4
1M
3
0.31
1
0.25
- Areas of investment
Summary
Princeton Biopharma Capital Partners appeared to be the VC, which was created in 2010. The company was established in North America in United States. The main office of represented VC is situated in the New York.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2016.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Consumer Electronics. Among the most popular portfolio startups of the fund, we may highlight ActiveProtective. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
We also calculated 3 valuable employees in our database.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Princeton Biopharma Capital Partners, startups are often financed by Sacha Levy, Philadelphia College of Osteopathic Medicine, Key Safety Systems. The meaningful sponsors for the fund in investment in the same round are Sacha Levy, Philadelphia College of Osteopathic Medicine, New York Angels.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Rounds per year
- 0.31
- Follow on index
- 0.25
- Investments by industry
- Health Care (4)
- Medical Device (3)
- Consumer Electronics (2)
- Biotechnology (1)
- Investments by region
-
- United States (4)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ActiveProtective | 22 Nov 2016 | Health Care, Medical Device, Consumer Electronics | Seed | 2M | United States, Pennsylvania, Allentown |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.